Israel Englander’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,986
Closed -$388K 6036
2025
Q4
$388K Sell
3,986
-2,601
-39% -$246K ﹤0.01% 5106
2025
Q3
$584K Buy
+6,587
New +$569K ﹤0.01% 4976
2025
Q1
Sell
-4,024
Closed -$346K 6133
2024
Q4
$346K Buy
+4,024
New +$372K ﹤0.01% 4993
2023
Q4
Sell
-4,500
Closed -$371K 6306
2023
Q3
$371K Sell
4,500
-562
-11% -$47.7K ﹤0.01% 4825
2023
Q2
$430K Buy
+5,062
New +$432K ﹤0.01% 4650
2021
Q2
Sell
-4,979
Closed -$384K 6786
2021
Q1
$384K Buy
+4,979
New +$383K ﹤0.01% 5036
2016
Q4
Sell
-4,954
Closed -$250K 3520
2016
Q3
$250K Sell
4,954
-764
-13% -$39.3K ﹤0.01% 2891
2016
Q2
$289K Buy
+5,718
New +$285K ﹤0.01% 2746
2016
Q1
Sell
-5,124
Closed -$263K 3468
2015
Q4
$263K Sell
5,124
-14
-0.3% -$720 ﹤0.01% 2968
2015
Q3
$253K Sell
5,138
-262
-5% -$14.1K ﹤0.01% 3000
2015
Q2
$294K Buy
5,400
+600
+13% +$33K ﹤0.01% 2892
2015
Q1
$259K Buy
4,800
+600
+14% +$31.5K ﹤0.01% 3134
2014
Q4
$209K Buy
+4,200
New +$209K ﹤0.01% 3607

Other funds holding IXJ

Israel Englander's IXJ Position: Q1 2026 in Review

Israel Englander sold out of iShares Global Healthcare ETF (IXJ) in Q1 2026, closing a stake of 3,986 shares — an estimated $388K sold.

Israel Englander first reported a position in IXJ in Q4 2014 and held it in 13 quarters. The position peaked at $584K in Q3 2025. 285 funds tracked by Wall St. Rank hold IXJ as of Q1 2026.

  • Israel Englander reported no remaining iShares Global Healthcare ETF position as of Q1 2026 after selling out during the quarter.
  • Israel Englander sold 3,986 iShares Global Healthcare ETF shares in Q1 2026, an estimated $388K.
  • Israel Englander first reported a position in iShares Global Healthcare ETF in Q4 2014 and held it in 13 quarters.
  • Israel Englander's iShares Global Healthcare ETF position peaked at $584K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.